“…However, 2 papers (Huang et al, 2006;Ye et al, 2008) were ruled out for the studies on premalignant lesion instead of cancer. As a result, 17 papers (Matthias et al, 1998;Zheng et al, 2001;Deng et al, 2002;Wong et al, 2003;Monteiro et al, 2004;Nishimoto et al, 2004;Holley et al, 2005;Catarino et al, 2006;Rydzanicz et al, 2006;Sathyan et al, 2006;Gomes et al, 2008;Marsit et al, 2008;Sui et al, 2009;Jelonek et al, 2010;Tsai et al, 2011;Shih et al, 2012;Sabir et al, 2013) comprising seventeen eligible studies with 3,761 cases and 3,834 controls for CCND1 G870A as well as three eligible studies (Sathyan et al, 2006;Tsai et al, 2011;Shih et al, 2012) with 943 cases and 935 controls for CCND1 G1722C were included. With regard to CCND1 G870A, seven studies (Matthias et al, 1998;Zheng et al, 2001;Monteiro et al, 2004;Holley et al, 2005;Catarino et al, 2006;Rydzanicz et al, 2006;Jelonek et al, 2010) were performed in Caucasians and seven (Deng et al, 2002;Wong et al, 2003;Sathyan et al, 2006;Sui et al, 2009;Tsai et al, 2011;Shih et al, 2012;Sabir et al, 2013) were conducted in Asians and three …”